These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22960405)

  • 1. Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat.
    Hellström PM; Smithson A; Stowell G; Greene S; Kenny E; Damico C; Leone-Bay A; Baughman R; Grant M; Richardson P
    Regul Pept; 2012 Nov; 179(1-3):71-6. PubMed ID: 22960405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
    J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome.
    Hellström PM; Näslund E; Edholm T; Schmidt PT; Kristensen J; Theodorsson E; Holst JJ; Efendic S
    Neurogastroenterol Motil; 2008 Jun; 20(6):649-59. PubMed ID: 18298441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat.
    Bozkurt A; Näslund E; Holst JJ; Hellström PM
    Regul Pept; 2002 Jul; 107(1-3):129-35. PubMed ID: 12137975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway.
    Tolessa T; Näslund E; Hellström PM
    Regul Pept; 2001 Apr; 98(1-2):33-40. PubMed ID: 11179776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
    Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
    Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 analogue LY315902: effect on intestinal motility and release of insulin and somatostatin.
    Näslund E; Skogar S; Efendic S; Hellström PM
    Regul Pept; 2002 Jun; 106(1-3):89-95. PubMed ID: 12047915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1: broadening the incretin concept to involve gut motility.
    Hellström PM
    Regul Pept; 2009 Aug; 156(1-3):9-12. PubMed ID: 19362109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models.
    Chen Y; Li Z; Yang Y; Lin L; Zhang H
    Int J Mol Med; 2013 Mar; 31(3):607-13. PubMed ID: 23338623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromedin-N inhibits migrating myoelectric complex and induces irregular spiking in the small intestine of rats; comparison with neurotensin.
    Schultz I; Wallin B; Mogard MH; Hellström PM
    Regul Pept; 1991 Sep; 35(3):197-205. PubMed ID: 1758975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans.
    Halim MA; Degerblad M; Sundbom M; Karlbom U; Holst JJ; Webb DL; Hellström PM
    J Clin Endocrinol Metab; 2018 Feb; 103(2):575-585. PubMed ID: 29177486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrergic inhibition of migrating myoelectric complex in the rat is mediated by vasoactive intestinal peptide.
    Hellström PM; Ljung T
    Neurogastroenterol Motil; 1996 Dec; 8(4):299-306. PubMed ID: 8959734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological regulation and NO-dependent inhibition of migrating myoelectric complex in the rat small bowel by OXA.
    Ehrström M; Näslund E; Ma J; Kirchgessner AL; Hellström PM
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G688-95. PubMed ID: 12816759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in the effects of various doses of cerulein upon the small-intestinal migrating motor complex in fasted and non-fasted sheep.
    Romański KW
    J Anim Physiol Anim Nutr (Berl); 2007 Feb; 91(1-2):29-39. PubMed ID: 17217388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
    Punjabi M; Arnold M; Rüttimann E; Graber M; Geary N; Pacheco-López G; Langhans W
    Endocrinology; 2014 May; 155(5):1690-9. PubMed ID: 24601880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.
    Wen J; Phillips SF; Sarr MG; Kost LJ; Holst JJ
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G945-52. PubMed ID: 8572226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.